United States HR 8588: Improving the American Drug Supply Chain Act of 2020

Status: Introduced in House (as of 2020-10-13)

State: United States · Session: 116 · Bill: HR 8588

Subjects: Congressional oversight, Drug safety, medical device, and laboratory regulation, Economic performance and conditions, Emergency medical services and trauma care, Emergency planning and evacuation, Government studies and investigations, Health care costs and insurance, Health technology, devices, supplies, Intellectual property, Labor market, Manufacturing, Prescription drugs

Sponsors: Richard Hudson, Lisa Blunt Rochester

View United States HR 8588 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.